(Q36440803)

14 August 2017

Racial differences in oncogene mutations detected in early-stage low-grade endometrial cancers (English)

1 reference

14 August 2017

Michele L Cote

1

1 reference

14 August 2017

Govindaraja Atikukke

2

1 reference

14 August 2017

Julie J Ruterbusch

3

1 reference

14 August 2017

Sara H Olson

4

1 reference

14 August 2017

Shawnita Sealy-Jefferson

5

1 reference

14 August 2017

Benjamin A Rybicki

6

1 reference

14 August 2017

Sharon Hensley Alford

7

1 reference

14 August 2017

Mohammad A Elshaikh

8

1 reference

14 August 2017

Arthur R Gaba

9

1 reference

14 August 2017

Daniel Schultz

10

1 reference

14 August 2017

Ramsi Haddad

11

1 reference

14 August 2017

Adnan R Munkarah

12

1 reference

14 August 2017

Rouba Ali-Fehmi

13

1 reference

14 August 2017

1 October 2012

1 reference

International Journal of Gynecological Cancer

14 August 2017

1 reference

14 August 2017

22

1 reference

14 August 2017

8

1 reference

14 August 2017

1367-1372

1 reference

A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Rare cancer-specific mutations in PIK3CA show gain of function

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

High frequency of mutations of the PIK3CA gene in human cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

The phosphoinositide 3-kinase pathway

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Survival of blacks and whites after a cancer diagnosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Mutations of the Ki-ras oncogene in carcinoma of the endometrium.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Two pathogenetic types of endometrial carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512561

Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis

21 September 2018

1 reference

12 December 2020

K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age of patient

1 reference

12 December 2020

Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival

1 reference

12 December 2020

PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters

1 reference

12 December 2020

Rare mutations in the PIK3CA gene contribute to aggressive endometrial cancer

1 reference

12 December 2020

10.1097/IGC.0B013E31826B1110

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

23013731

1 reference